Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR183 | P32249 | 10/20 | 0.64 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | STAT3 | P40763 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.56 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | F3 | P13726 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21957483 | 0.94 | ALOX5 (0.61) | GPR183KCNH2STAT3NPC1ALDH1A1 | |
| SCHEMBL25307114 | 0.93 | ALOX5 (0.60) | GPR183KCNH2STAT3NPC1ALDH1A1 | |
| SCHEMBL21428143 | 0.90 | GPR183 (0.62) | GPR183KCNH2STAT3NPC1ALDH1A1 | |
| SCHEMBL21428073 | 0.89 | GPR183 (0.61) | GPR183KCNH2STAT3NPC1ALDH1A1 | |
| SCHEMBL21428072 | 0.87 | GPR183 (0.62) | GPR183KCNH2STAT3NPC1ALDH1A1 | |
| SCHEMBL14441226 | 0.86 | PTGS2 (0.62) | GPR183MAPTSTAT3NPC1ALDH1A1 | |
| SCHEMBL21427990 | 0.86 | GPR183 (0.61) | GPR183KCNH2STAT3NPC1ALDH1A1 | |
| SCHEMBL6786761 | 0.86 | ALOX5 (0.57) | GPR183MAPTNPC1ALDH1A1RAB9A | |
| SCHEMBL21957510 | 0.86 | GAA (0.61) | GPR183KCNH2STAT3NPC1ALDH1A1 | |
| SCHEMBL21428450 | 0.85 | NPC1 (0.62) | GPR183KCNH2MAPTSTAT3NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6828316-B2 | Antiallergens | KOWA CO., LTD. (JP) | 2004-12-07 | — | — | US | disclosed |
| US-20020042414-A1 | Diamide compound and medicine containing the same | KOWA CO., LTD. (JP) | 2002-04-11 | — | — | US | disclosed |
| US-6340682-B1 | FOR THERAPY OF ALLERGIC IMMUNOLOGICAL DISEASE IS SELECTED FROM ASTHMA, ALLERGIC RHINITIS, INFLAMMATORY LARGE BOWEL DISEASE OR CONTACT DERMATITIS | KOWA CO., LTD. (JP) | 2002-01-22 | — | — | US | disclosed |
| EP-0926138-A1 | DIAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME | KOWA CO. LTD. (JP) | 1999-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020042414-A1 | Diamide compound and medicine containing the same | HRH4, HRH2, HRH1 | GPR183 1153/4885KCNH2 59/4885MAPT 3453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.